CAPSONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.804
EU - Europa 12.299
AS - Asia 9.395
SA - Sud America 1.383
Continente sconosciuto - Info sul continente non disponibili 348
AF - Africa 225
OC - Oceania 17
Totale 44.471
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.350
IT - Italia 3.577
SG - Singapore 2.847
RU - Federazione Russa 2.469
CN - Cina 2.184
SE - Svezia 1.632
IE - Irlanda 1.264
KR - Corea 1.093
BR - Brasile 1.015
DE - Germania 927
TR - Turchia 760
VN - Vietnam 663
UA - Ucraina 628
HK - Hong Kong 576
GB - Regno Unito 512
FI - Finlandia 378
FR - Francia 275
CA - Canada 263
BD - Bangladesh 257
IN - India 240
CH - Svizzera 132
AR - Argentina 118
AT - Austria 103
JP - Giappone 96
IQ - Iraq 87
MX - Messico 76
ID - Indonesia 71
NL - Olanda 70
IL - Israele 69
VE - Venezuela 68
PK - Pakistan 66
PH - Filippine 62
ZA - Sudafrica 61
ES - Italia 60
CO - Colombia 59
BE - Belgio 58
PL - Polonia 57
SA - Arabia Saudita 55
EC - Ecuador 47
EU - Europa 47
UZ - Uzbekistan 45
MY - Malesia 36
AE - Emirati Arabi Uniti 29
MA - Marocco 29
CL - Cile 28
EG - Egitto 27
AL - Albania 26
JM - Giamaica 22
TN - Tunisia 21
KE - Kenya 19
CR - Costa Rica 18
LT - Lituania 18
JO - Giordania 17
TW - Taiwan 17
PE - Perù 16
PY - Paraguay 15
TH - Thailandia 15
DZ - Algeria 14
HN - Honduras 14
AU - Australia 13
CZ - Repubblica Ceca 13
DK - Danimarca 12
RS - Serbia 12
AZ - Azerbaigian 11
LB - Libano 11
LU - Lussemburgo 11
NI - Nicaragua 11
NP - Nepal 11
ET - Etiopia 10
PS - Palestinian Territory 10
HU - Ungheria 9
KZ - Kazakistan 9
PT - Portogallo 9
OM - Oman 8
SV - El Salvador 8
BN - Brunei Darussalam 7
BO - Bolivia 7
EE - Estonia 7
PA - Panama 7
RO - Romania 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
GT - Guatemala 6
GE - Georgia 5
KG - Kirghizistan 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BG - Bulgaria 4
BS - Bahamas 4
BW - Botswana 4
CW - ???statistics.table.value.countryCode.CW??? 4
IR - Iran 4
LY - Libia 4
MD - Moldavia 4
MN - Mongolia 4
NG - Nigeria 4
PR - Porto Rico 4
SC - Seychelles 4
SN - Senegal 4
Totale 44.094
Salva come PNG Salva come JPEG
Città #
Pisa 2.203
Ashburn 2.014
Dallas 1.707
Council Bluffs 1.684
San Jose 1.618
Singapore 1.548
Chandler 1.373
Jacksonville 1.307
Dublin 1.258
Seoul 1.083
Boardman 920
Moscow 575
Izmir 533
Wilmington 529
Hong Kong 521
Hefei 411
Ann Arbor 399
The Dalles 375
New York 335
Boston 311
Los Angeles 295
Beijing 282
Clifton 277
Millbury 264
Düsseldorf 227
Munich 215
Kent 192
Mestre 188
Milan 187
Ho Chi Minh City 185
San Mateo 181
Lauterbourg 170
Istanbul 166
Hanoi 157
Helsinki 140
Chicago 128
Seattle 125
Santa Clara 122
Ogden 121
Bremen 119
North Bergen 119
Princeton 109
Bern 107
Toronto 106
São Paulo 102
Washington 101
Lawrence 92
Vienna 92
Rome 90
Woodbridge 88
Buffalo 80
Frankfurt am Main 76
Tokyo 76
Orem 73
San Antonio 72
Guangzhou 69
San Paolo di Civitate 67
Saint Petersburg 63
Figino 61
Shanghai 60
Columbus 58
Atlanta 55
Denver 54
Phoenix 54
Dearborn 53
Montreal 53
Turku 53
Brussels 51
Holon 51
Chennai 49
London 47
Warsaw 46
Brooklyn 43
Houston 41
Wuhan 41
Norwalk 40
Dong Ket 39
Scuola 38
Da Nang 37
Amsterdam 36
Tashkent 36
Baghdad 35
Keene 35
Jakarta 34
Stockholm 33
San Giuliano Terme 30
Mexico City 29
Rio de Janeiro 29
Dhaka 28
Johannesburg 27
Las Vegas 27
Philadelphia 27
Belo Horizonte 26
Brasília 26
Caracas 26
Fairfield 26
Haiphong 26
San Francisco 26
Florence 25
Naples 25
Totale 27.663
Salva come PNG Salva come JPEG
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.660
Graphene promotes axon elongation through local stall of Nerve Growth Factor signaling endosomes 531
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 480
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 444
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 412
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 407
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 403
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 355
NGF steers microglia toward a neuroprotective phenotype 347
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 341
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 335
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 334
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 326
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 325
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 324
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. 317
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 314
A small molecule targeting the multifactorial nature of Alzheimer's disease 312
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 309
A new generation of NGF-based therapy for Alzheimer’s disease 305
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 305
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 303
Targeting the cation-chloride co-transporter NKCC1 to re-establish GABAergic inhibition and an appropriate excitatory/inhibitory balance in selective neuronal circuits: a novel approach for the treatment of Alzheimer's disease 301
Abeta-Dependent Inhibition of LTP in Different Intra-Cortical Circuits of the Visual Cortex: The role of RAGE 296
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 296
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 293
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 290
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 288
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 282
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 276
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 275
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 267
A microglial function for the nerve growth factor : predictions of the unpredictable 266
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 266
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 265
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 265
Human TrkAR649W mutation impairs nociception, sweating and cognitive abilities : a mouse model of HSAN IV 263
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 263
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 262
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 262
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 260
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology 260
Environmental enrichment rescues visual memory deficits in a mouse model of Alzheimer disease 256
Delivery of NGF to the Brain: Intranasal Versus Ocular Administration in Anti-NGF Transgenic Mice 256
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 255
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 252
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection 249
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 249
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 244
Nerve Growth Factor regulates astrocyte physiology in vivo 243
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 242
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 241
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 241
Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome 240
Development of a non-invasive NGF-based therapy for Alzheimer's disease. Current Alzheimer Research 6: 158 240
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 239
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 237
IN VITRO RECEPTOR BINDING PROPERTIES OF A "PAINLESS" NGF MUTEIN, LINKED TO HEREDITARY SENSORY AUTONOMIC NEUROPATHY TYPE V 237
Morphological basis for pineal secretion in domestic Ungulata 237
Reduced levels of NGF shift astrocytes toward a neurotoxic phenotype 234
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 234
Intranasal delivery of therapeutic proteins for neurological diseases 234
Amelioration of the neurodegenerative phenotype in AD11 anti-NGF mice 230
Nerve Growth Factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 229
Involvement of NGF in early stages of chick embryo development 229
ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic Mice 228
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J Alzheimers Dis 16: 371 226
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 225
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 224
The role of Nerve Growth Factor in development and in ALzheimer's disease 223
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. 221
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction 220
Rat visual cortical neurones express TrkA NGF receptor 218
Role of NGF in modulating adult neurogenesis in an Alzheimer's disease mouse model 218
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 217
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer disease 211
Nerve growth factor regulates axial rotation during early stages of chick embryo development 210
PHENOTYPIC KNOCKOUT OF NERVE GROWTH FACTOR IN ADULT TRANSGENIC MICE REVEALS SEVERE DEFICITS IN BASAL FOREBRAIN CHOLINERGIC NEURONS, CELL DEATH IN THE SPLEEN, AND SKELETAL MUSCLE DYSTROPHY 210
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 210
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 209
Memoquin: a new compound to attack Alzheimer disease on multiple fronts 209
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 205
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 205
The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model 205
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 204
Understanding pain perception through genetic painlessness diseases : the role of NGF and proNGF 203
BDNF intranasal administration rescues visual memory deficits in a mouse model of Alzheimer disease (AD), the AD11 mouse 202
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 202
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 200
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 200
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice 199
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 198
Long-term memantine treatment prevents behaviour deficits in a mouse model of sporadic Alzheimer's disease 198
Expression of the melatonin receptors in Xenopus laevis 196
Beta amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies 195
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 195
Endogenous Aβ causes cell death via early tau hyperphosphorylation 195
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 195
Environmental enrichment rescues visual memory deficits in a mouse model of Alzheimer disease after the onset of neurodegeneration 194
Early involvement of inflammation and immune response mRNAs in the brain of anti-Nerve Growth Factor AD11 mice, as revealed by gene expression profiling 194
Totale 28.497
Salva come PNG Salva come JPEG
Categoria #
all - tutte 220.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.304 0 0 0 78 99 19 31 127 92 76 71 711
2022/20236.174 413 377 260 427 382 599 4 1.562 1.850 33 124 143
2023/20241.912 268 47 215 47 137 388 72 104 207 72 10 345
2024/20258.711 1.664 292 268 738 899 180 589 334 1.255 426 978 1.088
2025/202615.850 928 1.432 2.155 1.426 1.025 656 2.643 951 2.181 1.129 715 609
2026/20273.875 718 546 640 1.971 0 0 0 0 0 0 0 0
Totale 44.471